Proclamation 11020 gave companies a way to pay 20 percent instead of 100 percent on imported patented pharmaceuticals. The price is an onshoring plan approved by the Secretary of Commerce, and the Bureau of Industry and Security expects applicants to move as much global production as possible by 20 January 2029.
That date is the problem. Not because it is unreasonable on its own, but because it is the same date for everyone.
Dozens of companies are now working backwards from one horizon, in one labor market, competing for the same people. Capital can be raised in parallel. Buildings can be built in parallel. Experienced quality and validation staff cannot be manufactured in parallel, because the thing that makes them useful takes years to acquire.
This post is about which roles actually run short, why they cannot be filled quickly, and what a site can realistically do about it.
Why This Shortage Is Different
Pharma has had hiring squeezes before. They were usually broad and cyclical, and they resolved because the industry as a whole slowed down or sped up together.
This one is narrow and structural.
It is narrow because most site roles are not affected. Production operators, warehouse staff, general QA document control – these can be recruited locally and trained on a normal timeline. The constraint sits in a handful of specialised roles.
It is structural because the deadline is set by policy, not by demand. A company that falls behind cannot decide to go slower. Falling behind means milestone reports to Commerce showing slippage, and those reports may be audited externally.
The combination is unusual. Everyone needs the same scarce people, at the same time, and nobody can opt out of the timetable.
The Five Roles That Run Short
From the shape of the work a transfer requires, five roles carry the constraint.
1. CQV and validation engineers
Commissioning, qualification and validation is the gate between a finished building and a licensed facility. Every system, every utility, every piece of equipment needs a documented qualification trail before anything commercial can run.
The work is front-loaded and enormous at a new site, then drops to a maintenance level. That shape is why companies rarely keep enough CQV capacity on staff, and why everyone reaches for the same contract market at the same moment.
2. Technology transfer leads who have done one before
A transfer lead coordinates process, analytical methods, regulatory filings, supply and the receiving site, usually across time zones and organisations. Almost none of that is written down anywhere.
The distinguishing qualification is having completed one, because most of the job is knowing what goes wrong. Someone leading their first transfer will do the documented steps correctly and be surprised by the undocumented ones.
3. Aseptic processing subject matter experts
Sterile manufacturing carries the highest consequence and the least tolerance for learning on the job. Aseptic judgment – recognising that an intervention was performed badly, that a gowning sequence has drifted, that a media fill result is not what it appears – comes from years on a line.
You cannot generate this from a training curriculum, and the current expansion in sterile capacity is competing for a population that was already thin.
4. Computer system validation and data integrity specialists
New sites arrive with more automation than the sites they replace. Electronic batch records, e-QMS platforms, historians, building management systems, all of it validated and all of it subject to data integrity expectations.
The scarce skill is not IT and it is not QA. It is the person who understands both well enough to decide what a control actually needs to be, and to defend that decision to an investigator.
5. Quality staff who have worked a pre-approval inspection
This is the scarcest of the five and the least substitutable.
A PAI examines whether the facility can make the product as described, whether the submitted data are accurate and complete, and whether the site is in a state of control. Preparing for one is a discipline of its own: knowing what will be asked, how records will be read, which answers create follow-up questions.
None of that can be trained into someone. It is acquired by having been in the room. The population who have been in the room is fixed in the short run, and every company standing up new capacity is bidding for them simultaneously.
What Cannot Be Solved by Hiring
There is a hard limit here that budgets do not fix. If the industry needs more people with inspection experience than exist, no amount of salary competition creates additional ones. It only redistributes them, at higher cost, with more disruption.
Two consequences follow for site leadership.
First, retention of the people you already have is worth more than it was eighteen months ago. The person on your team who has worked two PAIs is now a market-priced asset who is being contacted.
Second, some of this capability has to be built rather than bought, which takes time you only have if you start now.
What Actually Works
Pair, do not just hire. Where you bring in an experienced transfer lead or PAI-experienced quality manager, attach someone internal to them explicitly to absorb the knowledge. The engagement then produces two assets instead of one. This has to be a stated deliverable, not a hope.
Be honest about what is core and what is peak load. CQV is peak load; a contract market exists for it and using that market is sensible. Investigation capability is core, because it stays load-bearing long after start-up. Outsourcing the second because the first worked is a common and expensive error.
Recruit against the 2029 date, not the construction date. Mechanical completion is not the milestone that matters. The milestone is a licensed, inspected, operating site, and the people who deliver that need to be in place well before commissioning ends.
Treat inspection readiness as a capability, not an event. Sites that prepare for a PAI in the final quarter are relying entirely on individuals who have done it before. Sites that build the underlying discipline – investigations that reach root cause, records that survive reading, data that reconciles – depend less on scarce individuals.
That last point is the practical answer to the shortage. The scarcer PAI experience becomes, the more valuable it is to have a quality system that does not require heroics to pass an inspection.
For People Choosing Where to Go Next
If you work in quality or validation, the same analysis reads as opportunity.
The skills that are appreciating fastest are the ones tied to standing up and licensing new capacity: qualification and validation, technology transfer, aseptic operations, computer system validation and data integrity, and direct inspection exposure.
One piece of advice worth stating plainly. If your organisation is preparing for a pre-approval inspection and you can get near it, do. Ask to support the readiness work, sit in on the preparation, take the back-room role during the inspection itself. That experience is the least trainable and most sought-after credential in the current market, and the only way to obtain it is proximity.
Conclusion
Onshoring commitments were made on an economic case and will be met, or missed, on a staffing one.
The constraint is not general. It sits in five roles, of which prior inspection experience is the hardest to obtain and the easiest to lose. Companies that address this now – by retaining what they have, pairing new hires with internal successors, and building an inspection-ready quality system rather than relying on inspection-experienced individuals – will hit the 2029 horizon.
Those that treat hiring as something to sort out once the building is finished will discover that the building was never the constraint.
Key Takeaways
The 2029 onshoring horizon is shared. BIS expects approved companies to onshore as much production as possible by 20 January 2029, which puts every applicant in the same labor market at the same time.
The shortage is narrow, not general. Five roles carry it: CQV and validation, technology transfer leads, aseptic SMEs, CSV and data integrity, and PAI-experienced quality staff.
Inspection experience cannot be trained. It is acquired by proximity, which makes it the hardest constraint to solve with budget.
Retention now matters more than recruitment. Your PAI-experienced people are market-priced and are being contacted.
Pair external hires with internal successors as a stated deliverable, so an engagement leaves capability behind.
An inspection-ready quality system reduces dependence on scarce individuals. That is the durable answer to a talent shortage you cannot out-hire.
Sources: Procedures To Apply for Company-Specific Onshoring Agreements for Pharmaceuticals and Pharmaceutical Ingredients Under Proclamation 11020, 91 FR 26989 (13 May 2026); Proclamation 11020, 91 FR 18183 (9 April 2026).
Related reading: Your Tech Transfer Schedule Is Now a Tariff Input, Inspection & Audit Management, and Remediation & Transformation PMO.